| Name | Title | Contact Details |
|---|
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to concentrate on high growth potential markets where there are visible, distinct needs recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use.
CARTI is a multi-disciplinary cancer care provider with locations throughout Arkansas. Providing medical, radiation, interventional and surgical oncology, as well as diagnostic radiology, CARTI cares for more than 20,000 cancer patients each year.
Hometown Health is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Harbor House Senior Residence is a Oyster Bay, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.